{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:49:40Z","timestamp":1781606980648,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jneuroim.2022.577861","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:01:42Z","timestamp":1649070102000},"page":"577861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients"],"prefix":"10.1016","volume":"367","author":[{"given":"Iman","family":"McKeon-Makki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McKeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lopez-Chiriboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Miske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Zekeridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577861_bb0005","first-page":"vdab145","article-title":"Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes","volume":"3","author":"Bastiaansen","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576975","article-title":"Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: three new cases and a review of the literature","volume":"334","author":"Bien","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000701","article-title":"Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes","volume":"7","author":"Dechelotte","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","article-title":"Metabotropic glutamate receptor type 1 autoimmunity: clinical features and treatment outcomes","volume":"86","author":"Lopez-chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0040","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","article-title":"Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis","volume":"144","author":"Muniz-Castrillo","year":"2021","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2015.08.009","article-title":"Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis","volume":"287","author":"Ng","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2007.03.015","article-title":"Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis","volume":"186","author":"Tuzun","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2022.577861_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1126\/science.6385251","article-title":"High-performance liquid chromatography-mass spectrometry","volume":"226","author":"Vestal","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0060","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001010","article-title":"Anti-adenylate kinase 5 encephalitis with histologic evidence of CNS Vasculitis","volume":"8","author":"Vicino","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jneuroim.2022.577861_bb0065","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000007971","article-title":"Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity","volume":"93","author":"Zekeridou","year":"2019","journal-title":"Neurology."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282200056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282200056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:11Z","timestamp":1759048871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282200056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":13,"alternative-id":["S016557282200056X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577861","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577861"}}